fda category 2 bulk drug substances bpc-157 compounding list RFK Jr.'s peptide push could unleash risky drugs BPC-157 - Phoenix Peptide Labs

Significance of Negative Post-Treatment 18-FDG PET/CT Imaging in Patients with p16/HPV-positive Oropharyngeal Cancer

A reasonable bar would be at least one published phase 2 trial showing clinical efficacy with acceptable safety in humans

Well look into this research and its treatment implications

Acknowledgments During the preparation of this work, the author(s) used ChatGPT (GPT-5, OpenAI, San Francisco, CA, USA) and Perplexity AI Pro (PPLX-70B, Perplexity, San Francisco, CA, USA) in order to assist with bibliographic searches and language editing when necessary

Salvio G, Cutini M, Ciarloni A, Giovannini L, Perrone M, Balercia G